Is WHO ready to end the Covid emergency?; substandard children's chemo drug shipped around the world

An emergency committee will gather as Covid rips for the first time through the world's most populous nation.‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

January 25, 2023 Check out STAT+

Sponsored By

FABRICE COFFRINI/AFP via Getty Images Is WHO ready to end the global health emergency over Covid? Maybe not just yet An emergency committee will gather as Covid rips for the first time through the world's most populous nation. By Helen Branswell The drug was meant to save children's lives. Instead, they're dying Substandard asparaginase, a childhood leukemia drug, has been shipped to more than 90 countries, overwhelmingly from companies in India. By Rosa Furneaux and Laura Margottini — TBIJ STAT+ | The 4 biggest questions about the FDA's forthcoming changes to accelerated approvals Congress just boosted the FDA's authority over the post-market clinical trials that are a condition of speedy drug approvals. By John Wilkerson FREDERIC J. BROWN/AFP via Getty Images Updated Covid-19 booster still providing strong protection against newer variants, CDC study finds The protection offered by the updated Covid booster appears to be holding up against the newest Omicron subvariants. By Helen Branswell STAT+ | Focused exclusively on life sciences, three top investors set out on their own Dimension, led by Zavain Dar, Adam Goulburn, and Nan Li, launched Wednesday with $350 million for its first fund. By Allison DeAngelis STAT+ | Vir CEO George Scangos to retire, after pandemic success George Scangos, 74, will retire after nearly 40 itinerant years, including at Bayer and a turnaround stint at Biogen. By Jason Mast Mary Altaffer/AP Opinion: Making naloxone available over the counter won't solve the overdose crisis — but it will help Making naloxone, an overdose-reversal drug, available over-the- counter would be an important step for easing the opioid overdose crisis. By Stacey McKenna

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

REPORTS NEWSLETTERS EVENTS STAT+

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser